Back

Assessment of endogenous fibrinolysis using a point-of-care assay to identify increased cardiovascular risk in patients with diabetes and ACS

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Thrombosis and Inflammation in Acute Coronary Syndrome: Insights from Translational Research Thrombosis, Platelets, and Coagulation ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Rahim Kanji

National Heart and Lung Institute, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
No difference in thrombotic profile of patients with ACS with obstructive CAD and MINOCA
Doctor R. Kanji (London, GB)
Abstract Slides
Presentation thumbnail
Coronary plaque instability is associated with inflammatory activity of visceral adipose tissue and carotid artery: a prospective pilot F-18 FDG PET/CT study
Doctor K. Pahk (Seoul, KR)
Abstract Slides
Presentation thumbnail
Acquired von Willebrand Syndrome in left Impella supported cardiogenic shock patients
Doctor C. Vandenbriele (London, GB)
Abstract Slides
Presentation thumbnail
Association between hypercoagulability and microvascular dysfunction in patients with acute myocardial infarction
Doctor M. Kang (Jinju, KR)
Abstract Slides
Presentation thumbnail
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome-dependent pyroptosis
Mr A. Chen (Shanghai, CN)
Abstract Slides

Access the full session

Session thumbnail
Thrombosis and Inflammation in Acute Coronary Syndrome: Insights from Translational Research

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources